Antibody targets mechanism that enables lung cancer to grow and spread
Covid-19: Failures of leadership, national and global
17 June 2021Covid-19: Regeneron’s antibody combination cuts deaths in seronegative patients, trial finds
17 June 2021Antibody targets mechanism that enables lung cancer to grow and spread
An investigational antibody in clinical trials for lung cancer appears to disrupt a mechanism that tumor cells exploit to avoid being destroyed by the body’s innate immune system, researchers at Duke Health report.
